AstraZeneca PLC (AZN)
Discovers and manufactures prescription medicines for cancer, heart disease, and respiratory conditions
$171.43+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+15.9%
The outlook
AZN is trading below its 50- and 200-day moving averages, placing it in the lower half of its 52-week range. Analyst consensus leans Buy with an average price target about 25% above the current price. The stock carries a trailing P/E of 25.7 and shows a neutral overall score despite the positive analyst lean.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 10 analysts
Price trendBelow its 50- & 200-day averages
52-week range39% of the way from its 52-week low to high
Price targetAvg target +25% vs current price
Analyst price target
~12-month · 10 analysts$213.99average target+24.8% vs now
Now $171.43
Low $184.00High $240.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$212.71
52-wk low
$145.14
50-day avg
$180.12
200-day avg
$184.76
Trailing P/E
25.7